Israël - hébreu - Ministry of Health

novo nordisk ltd., israel - insulin (human) - תרחיף להזרקה - insulin (human) 100 iu/ml - insulin (human) - insulin (human) - treatment of diabetes mellitus.

Israël - hébreu - Ministry of Health

novo nordisk ltd., israel - insulin (human) - תרחיף להזרקה - insulin (human) 100 iu/ml - insulin (human) - insulin (human) - treatment of diabetes mellitus.

Israël - hébreu - Ministry of Health

eli lilly israel ltd - insulin lispro; insulin lispro as protamine - תרחיף להזרקה - insulin lispro 25 %; insulin lispro as protamine 75 % - insulin lispro - insulin lispro - humalog mix 25 kwikpen is indicated for the treatment of patients with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis.

Israël - hébreu - Ministry of Health

eli lilly israel ltd, israel - insulin lispro; insulin lispro as protamine - תרחיף להזרקה - insulin lispro 50 %; insulin lispro as protamine 50 % - insulin lispro - insulin lispro - humalog mix 50 kwikpen is indicated for the treatment of patients with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis.

Israël - hébreu - Ministry of Health

sanofi israel ltd - insulin glulisine - תמיסה להזרקה - insulin glulisine 100 u/ml - insulin glulisine - insulin glulisine - treatment of adults, adolescents and children, 6 years or older with diabetes mellitus, where treatment with insulin is required.

Israël - hébreu - Ministry of Health

csl behring ltd., israel - human fibrinogen - אבקה להמסה להזרקה\אינפוזיה - human fibrinogen 900 - 1300 mg / 1 vials - fibrinogen, human - fibrinogen, human - haemocomplettan p 1g/2g, fibrinogen concentrate (human) is indicated for the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia.haemocomplettan p 1g/2g is not indicated for dysfibrinogenemia.

Israël - hébreu - Ministry of Health

csl behring ltd., israel - human fibrinogen - אבקה להמסה להזרקה\אינפוזיה - human fibrinogen 1800 - 2600 mg / 1 vials - fibrinogen, human - fibrinogen, human - haemocomplettan p 1g/2g, fibrinogen concentrate (human) is indicated for the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia.haemocomplettan p 1g/2g is not indicated for dysfibrinogenemia.

Israël - hébreu - Ministry of Health

eli lilly israel ltd, israel - insulin lispro - תמיסה להזרקה - insulin lispro 100 u/ml - insulin lispro

Israël - hébreu - Ministry of Health

eli lilly israel ltd, israel - insulin lispro - תמיסה להזרקה - insulin lispro 200 u/ml - insulin lispro

Israël - hébreu - Ministry of Health

cts ltd - human fibrinogen; thrombin - sponge - thrombin 2 iu/cm2; human fibrinogen 5.5 mg/cm2 - human fibrinogen - human fibrinogen - tachosil is indicated for supportive treatment in surgery for improvement of haemostasis, to promote tissue sealing and for sutute support in vascular surgery where standard techniques are insufficient.